Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Initial Symptoms of Langerhans Cell Histiocytosis: A Case Series.

Atsumi Y, Saito Y, Hataya H, Yuza Y.

Glob Pediatr Health. 2019 Jun 19;6:2333794X19857377. doi: 10.1177/2333794X19857377. eCollection 2019.

2.

Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.

Hangai M, Urayama KY, Tanaka J, Kato K, Nishiwaki S, Koh K, Noguchi M, Kato K, Yoshida N, Sato M, Goto H, Yuza Y, Hashii Y, Atsuta Y, Mizuta S, Kato M.

Biol Blood Marrow Transplant. 2019 Apr 17. pii: S1083-8791(19)30237-X. doi: 10.1016/j.bbmt.2019.04.014. [Epub ahead of print]

PMID:
31002992
3.

Ewing's Sarcoma with Extension into Superior Vena Cava and Right Atrium.

Atsumi Y, Saito Y, Hataya H, Fukuzawa R, Yuza Y.

Indian J Surg Oncol. 2019 Mar;10(1):98-100. doi: 10.1007/s13193-018-0849-0. Epub 2019 Jan 3.

PMID:
30948882
4.

Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan.

Kawashima N, Iida M, Suzuki R, Fukuda T, Atsuta Y, Hashii Y, Inoue M, Kobayashi M, Yabe H, Okada K, Adachi S, Yuza Y, Kawa K, Kato K.

Int J Hematol. 2019 Apr;109(4):491-498. doi: 10.1007/s12185-019-02601-5. Epub 2019 Jan 29.

PMID:
30694451
5.

Pediatric oncologic emergencies: Clinical and imaging review for pediatricians.

Handa A, Nozaki T, Makidono A, Okabe T, Morita Y, Fujita K, Matsusako M, Kono T, Kurihara Y, Hasegawa D, Kumamoto T, Ogawa C, Yuza Y, Manabe A.

Pediatr Int. 2019 Feb;61(2):122-139. doi: 10.1111/ped.13755. Epub 2019 Feb 7. Review.

PMID:
30565795
6.

Genetic Profile and Microsatellite Instability in a Case of Secondary Esophageal Squamous Cell Carcinoma 12 Years After Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.

Akiyama M, Yamaoka M, Ohyama W, Yokoi K, Ashizuka S, Aizawa D, Ikegami M, Suzuki H, Ozaki K, Ida H, Yuza Y.

J Pediatr Hematol Oncol. 2018 Nov 28. doi: 10.1097/MPH.0000000000001355. [Epub ahead of print]

PMID:
30499911
7.

Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Kurosawa H, Tanizawa A, Muramatsu H, Tono C, Watanabe A, Shima H, Ito M, Yuza Y, Hamamoto K, Hotta N, Okada M, Saito AM, Manabe A, Mizutani S, Adachi S, Horibe K, Ishii E, Shimada H.

Pediatr Blood Cancer. 2018 Dec;65(12):e27368. doi: 10.1002/pbc.27368. Epub 2018 Aug 7.

PMID:
30084127
8.

Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.

Kato M, Kurata M, Kanda J, Kato K, Tomizawa D, Kudo K, Yoshida N, Watanabe K, Shimada H, Inagaki J, Koh K, Goto H, Kato K, Cho Y, Yuza Y, Ogawa A, Okada K, Inoue M, Hashii Y, Teshima T, Murata M, Atsuta Y.

Bone Marrow Transplant. 2019 Jan;54(1):68-75. doi: 10.1038/s41409-018-0221-6. Epub 2018 May 24.

PMID:
29795428
9.

Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.

Okano T, Imai K, Tsujita Y, Mitsuiki N, Yoshida K, Kamae C, Honma K, Mitsui-Sekinaka K, Sekinaka Y, Kato T, Hanabusa K, Endo E, Takashima T, Hiroki H, Yeh TW, Tanaka K, Nagahori M, Tsuge I, Bando Y, Iwasaki F, Shikama Y, Inoue M, Kimoto T, Moriguchi N, Yuza Y, Kaneko T, Suzuki K, Matsubara T, Maruo Y, Kunitsu T, Waragai T, Sano H, Hashimoto Y, Tasaki K, Suzuki O, Shirakawa T, Kato M, Uchiyama T, Ishimura M, Tauchi T, Yagasaki H, Jou ST, Yu HH, Kanegane H, Kracker S, Durandy A, Kojima D, Muramatsu H, Wada T, Inoue Y, Takada H, Kojima S, Ogawa S, Ohara O, Nonoyama S, Morio T.

J Allergy Clin Immunol. 2019 Jan;143(1):266-275. doi: 10.1016/j.jaci.2018.04.032. Epub 2018 May 18.

PMID:
29778502
10.

Kidney-protective Effect of Magnesium Supplementation in Cisplatin-containing Chemotherapy for Pediatric Cancer: A Retrospective Study.

Matsui M, Saito Y, Yamaoka S, Yokokawa Y, Morikawa Y, Makimoto A, Yuza Y.

J Pediatr Hematol Oncol. 2018 Jul;40(5):379-381. doi: 10.1097/MPH.0000000000001159.

PMID:
29683958
11.

Anemia Due to ABO Incompatibility in a Neonate.

Atsumi Y, Sakakibara H, Suzuki S, Yuza Y.

Indian J Pediatr. 2018 Sep;85(9):810-811. doi: 10.1007/s12098-018-2663-7. Epub 2018 Mar 23. No abstract available.

PMID:
29569078
12.

Regional evaluation of childhood acute lymphoblastic leukemia genetic susceptibility loci among Japanese.

Urayama KY, Takagi M, Kawaguchi T, Matsuo K, Tanaka Y, Ayukawa Y, Arakawa Y, Hasegawa D, Yuza Y, Kaneko T, Noguchi Y, Taneyama Y, Ota S, Inukai T, Yanagimachi M, Keino D, Koike K, Toyama D, Nakazawa Y, Kurosawa H, Nakamura K, Moriwaki K, Goto H, Sekinaka Y, Morita D, Kato M, Takita J, Tanaka T, Inazawa J, Koh K, Ishida Y, Ohara A, Mizutani S, Matsuda F, Manabe A.

Sci Rep. 2018 Jan 15;8(1):789. doi: 10.1038/s41598-017-19127-7.

13.

The North Wind and the Sun: Pediatric Antimicrobial Stewardship Program Combining Restrictive and Persuasive Approaches in Hematology-Oncology Ward and Hematopoietic Stem Cell Transplant Unit.

Horikoshi Y, Kaneko T, Morikawa Y, Isogai M, Suwa J, Higuchi H, Yuza Y, Shoji T, Ito K.

Pediatr Infect Dis J. 2018 Feb;37(2):164-168. doi: 10.1097/INF.0000000000001746.

PMID:
28827495
14.

Flow cytometric analysis as an additional predictive tool of treatment response in children with chronic-phase chronic myeloid leukemia treated with imatinib.

Shima H, Kiyokawa N, Miharu M, Tanizawa A, Kurosawa H, Watanabe A, Ito M, Tono C, Yuza Y, Muramatsu H, Hotta N, Okada M, Hamamoto K, Kajiwara R, Saito AM, Horibe K, Mizutani S, Adachi S, Ishii E, Shimada H.

Pediatr Blood Cancer. 2017 Sep;64(9). doi: 10.1002/pbc.26478. Epub 2017 Feb 24.

PMID:
28233439
15.

Factors associated with posttraumatic growth among parents of children with cancer.

Nakayama N, Mori N, Ishimaru S, Ohyama W, Yuza Y, Kaneko T, Kanda E, Matsushima E.

Psychooncology. 2017 Sep;26(9):1369-1375. doi: 10.1002/pon.4307. Epub 2016 Nov 30.

PMID:
27862674
16.

Effect of UGT2B17 deletion polymorphism on prognosis in pediatric cancer.

Ishimaru S, Yuza Y, Kaneko T, Urashima M.

Pediatr Int. 2017 Apr;59(4):427-431. doi: 10.1111/ped.13198. Epub 2017 Jan 5.

PMID:
27805301
17.

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.

Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, Yaguchi A, Terada K, Saito Y, Yoshimi A, Ogata-Kawata H, Sakamoto H, Kato M, Fujimura J, Hino M, Kinoshita A, Kakuda H, Kurosawa H, Kato K, Kajiwara R, Moriwaki K, Morimoto T, Nakamura K, Noguchi Y, Osumi T, Sakashita K, Takita J, Yuza Y, Matsuda K, Yoshida T, Matsumoto K, Hata K, Kubo M, Matsubara Y, Fukushima T, Koh K, Manabe A, Ohara A, Kiyokawa N; Tokyo Children’s Cancer Study Group (TCCSG).

Haematologica. 2017 Jan;102(1):118-129. doi: 10.3324/haematol.2016.151035. Epub 2016 Sep 15.

18.

Atypical clinical features of children with central nervous system tumor: Delayed diagnosis and switch in handedness.

Yokoi K, Yamaoka M, Miyata I, Nonaka Y, Yuza Y, Kawata S, Akiyama M, Yanagisawa T, Ida H.

Pediatr Int. 2016 Sep;58(9):923-6. doi: 10.1111/ped.13024. Epub 2016 Jul 21.

PMID:
27440052
19.

Helicobacter cinaedi bacteremia resulting from antimicrobial resistance acquired during treatment for X-linked agammaglobulinemia.

Toyofuku M, Tomida J, Kawamura Y, Miyata I, Yuza Y, Horikoshi Y.

J Infect Chemother. 2016 Oct;22(10):704-6. doi: 10.1016/j.jiac.2016.02.008. Epub 2016 Mar 31.

PMID:
27040158
20.

High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group.

Takahashi H, Watanabe T, Kinoshita A, Yuza Y, Moritake H, Terui K, Iwamoto S, Nakayama H, Shimada A, Kudo K, Taki T, Yabe M, Matsushita H, Yamashita Y, Koike K, Ogawa A, Kosaka Y, Tomizawa D, Taga T, Saito AM, Horibe K, Nakahata T, Miyachi H, Tawa A, Adachi S.

Br J Haematol. 2016 Aug;174(3):437-43. doi: 10.1111/bjh.14068. Epub 2016 Mar 31.

PMID:
27029412
21.

Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.

Keino D, Kinoshita A, Tomizawa D, Takahashi H, Ida K, Kurosawa H, Koike K, Ota S, Iwasaki N, Fujimura J, Yuza Y, Kiyotani C, Yamamoto S, Osumi T, Ueda T, Mochizuki S, Isoyama K, Hanada R, Tawa A, Manabe A, Toguchi Y, Ohara A.

Int J Hematol. 2016 Apr;103(4):416-22. doi: 10.1007/s12185-016-1937-y. Epub 2016 Jan 18.

PMID:
26781613
22.

First report of an Asian family with hemoglobin Evans [α2 62 (E11) Val → Met].

Ishimaru S, Saito Y, Yokokawa Y, Yuza Y, Kaneko T.

Pediatr Int. 2016 Apr;58(4):301-3. doi: 10.1111/ped.12775. Epub 2015 Dec 11.

PMID:
26662577
23.

Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group.

Kurosawa H, Tanizawa A, Tono C, Watanabe A, Shima H, Ito M, Yuza Y, Hotta N, Muramatsu H, Okada M, Kajiwara R, Moriya Saito A, Mizutani S, Adachi S, Horibe K, Ishii E, Shimada H.

Pediatr Blood Cancer. 2016 Mar;63(3):406-11. doi: 10.1002/pbc.25803. Epub 2015 Oct 20.

PMID:
26485422
24.

[Long-term follow-up program and transition medicine for childhood cancer survivors].

Yuza Y.

Gan To Kagaku Ryoho. 2014 Jan;41(1):15-9. Japanese.

PMID:
24423947
25.

Vesiculopustular eruption in neonate with trisomy 21 and transient myeloproliferative disorder.

Iwashita N, Sadahira C, Yuza Y, Yoshihashi H, Kondou M.

J Pediatr. 2013 Mar;162(3):643-4. doi: 10.1016/j.jpeds.2012.10.053. Epub 2012 Dec 7. No abstract available.

PMID:
23219445
26.

Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.

Suda T, Hama T, Kondo S, Yuza Y, Yoshikawa M, Urashima M, Kato T, Moriyama H.

BMC Cancer. 2012 Sep 20;12:416. doi: 10.1186/1471-2407-12-416.

27.

Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.

Cho J, Pastorino S, Zeng Q, Xu X, Johnson W, Vandenberg S, Verhaak R, Cherniack AD, Watanabe H, Dutt A, Kwon J, Chao YS, Onofrio RC, Chiang D, Yuza Y, Kesari S, Meyerson M.

Cancer Res. 2011 Dec 15;71(24):7587-96. doi: 10.1158/0008-5472.CAN-11-0821. Epub 2011 Oct 14.

28.

Functional mutation analysis of EGFR family genes and corresponding lymph node metastases in head and neck squamous cell carcinoma.

Hama T, Yuza Y, Suda T, Saito Y, Norizoe C, Kato T, Moriyama H, Urashima M.

Clin Exp Metastasis. 2012 Jan;29(1):19-25. doi: 10.1007/s10585-011-9425-5. Epub 2011 Sep 28.

PMID:
21953075
29.

Validation of the Japanese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module.

Tsuji N, Kakee N, Ishida Y, Asami K, Tabuchi K, Nakadate H, Iwai T, Maeda M, Okamura J, Kazama T, Terao Y, Ohyama W, Yuza Y, Kaneko T, Manabe A, Kobayashi K, Kamibeppu K, Matsushima E.

Health Qual Life Outcomes. 2011 Apr 10;9:22. doi: 10.1186/1477-7525-9-22.

30.

Rapid spontaneous regression of multicentric infantile myofibromatosis in the posterior fossa and lumbar vertebra.

Miwa T, Oi S, Nonaka Y, Tamogami R, Sasaki H, Akiyama M, Yuza Y, Yokoi K, Yokokawa Y, Ida H.

Childs Nerv Syst. 2011 Mar;27(3):491-6. doi: 10.1007/s00381-010-1306-8. Epub 2010 Oct 15. No abstract available.

PMID:
20949273
31.

Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation.

Sos ML, Rode HB, Heynck S, Peifer M, Fischer F, Klüter S, Pawar VG, Reuter C, Heuckmann JM, Weiss J, Ruddigkeit L, Rabiller M, Koker M, Simard JR, Getlik M, Yuza Y, Chen TH, Greulich H, Thomas RK, Rauh D.

Cancer Res. 2010 Feb 1;70(3):868-74. doi: 10.1158/0008-5472.CAN-09-3106. Epub 2010 Jan 26.

32.

Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.

Hama T, Yuza Y, Saito Y, O-uchi J, Kondo S, Okabe M, Yamada H, Kato T, Moriyama H, Kurihara S, Urashima M.

Oncologist. 2009 Sep;14(9):900-8. doi: 10.1634/theoncologist.2009-0058. Epub 2009 Sep 2. Erratum in: Oncologist. 2009 Oct;14(10):1050.

33.

Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.

Mikami-Terao Y, Akiyama M, Yuza Y, Yanagisawa T, Yamada O, Kawano T, Agawa M, Ida H, Yamada H.

Exp Eye Res. 2009 Aug;89(2):200-8. doi: 10.1016/j.exer.2009.03.008. Epub 2009 Mar 27.

PMID:
19328784
34.

Differences in CTG triplet repeat expansion in leukemic cells and normal lymphocytes from a 14-year-old female with congenital myotonic dystrophy.

Akiyama M, Yuza Y, Yokokawa Y, Yokoi K, Ariga M, Eto Y.

Pediatr Blood Cancer. 2008 Oct;51(4):563-5. doi: 10.1002/pbc.21654.

PMID:
18561181
35.

Effects of prednisolone on specifically expressed genes in pediatric acute B-lymphoblastic leukemia.

Akiyama M, Yamada O, Agawa M, Yuza Y, Yanagisawa T, Eto Y, Yamada H.

J Pediatr Hematol Oncol. 2008 Apr;30(4):313-6. doi: 10.1097/MPH.0b013e318161a28f.

PMID:
18391702
36.

Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells.

Mikami-Terao Y, Akiyama M, Yuza Y, Yanagisawa T, Yamada O, Yamada H.

Cancer Lett. 2008 Mar 18;261(2):226-34. Epub 2007 Dec 21. Erratum in: Cancer Lett. 2016 Jan 28;370(2):365.

PMID:
18096315
37.

Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitors.

Yuza Y, Glatt KA, Jiang J, Greulich H, Minami Y, Woo MS, Shimamura T, Shapiro G, Lee JC, Ji H, Feng W, Chen TH, Yanagisawa H, Wong KK, Meyerson M.

Cancer Biol Ther. 2007 May;6(5):661-7. Epub 2007 Feb 13.

PMID:
17495523
38.

Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

Lee JC, Vivanco I, Beroukhim R, Huang JH, Feng WL, DeBiasi RM, Yoshimoto K, King JC, Nghiemphu P, Yuza Y, Xu Q, Greulich H, Thomas RK, Paez JG, Peck TC, Linhart DJ, Glatt KA, Getz G, Onofrio R, Ziaugra L, Levine RL, Gabriel S, Kawaguchi T, O'Neill K, Khan H, Liau LM, Nelson SF, Rao PN, Mischel P, Pieper RO, Cloughesy T, Leahy DJ, Sellers WR, Sawyers CL, Meyerson M, Mellinghoff IK.

PLoS Med. 2006 Dec;3(12):e485.

39.

A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes.

Sharma SV, Gajowniczek P, Way IP, Lee DY, Jiang J, Yuza Y, Classon M, Haber DA, Settleman J.

Cancer Cell. 2006 Nov;10(5):425-35. Erratum in: Cancer Cell. 2009 Nov 6;16(5):448.

40.

Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors.

Thomas RK, Greulich H, Yuza Y, Lee JC, Tengs T, Feng W, Chen TH, Nickerson E, Simons J, Egholm M, Rothberg JM, Sellers WR, Meyerson ML.

Cold Spring Harb Symp Quant Biol. 2005;70:73-81.

PMID:
16869740
41.

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing.

Thomas RK, Nickerson E, Simons JF, Jänne PA, Tengs T, Yuza Y, Garraway LA, LaFramboise T, Lee JC, Shah K, O'Neill K, Sasaki H, Lindeman N, Wong KK, Borras AM, Gutmann EJ, Dragnev KH, DeBiasi R, Chen TH, Glatt KA, Greulich H, Desany B, Lubeski CK, Brockman W, Alvarez P, Hutchison SK, Leamon JH, Ronan MT, Turenchalk GS, Egholm M, Sellers WR, Rothberg JM, Meyerson M.

Nat Med. 2006 Jul;12(7):852-5. Epub 2006 Jun 25. Erratum in: Nat Med. 2006 Oct;12(10):1220.

PMID:
16799556
42.

Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.

Ji H, Zhao X, Yuza Y, Shimamura T, Li D, Protopopov A, Jung BL, McNamara K, Xia H, Glatt KA, Thomas RK, Sasaki H, Horner JW, Eck M, Mitchell A, Sun Y, Al-Hashem R, Bronson RT, Rabindran SK, Discafani CM, Maher E, Shapiro GI, Meyerson M, Wong KK.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7817-22. Epub 2006 May 3.

43.

Allogenic bone marrow transplantation for late-infantile neuronal ceroid lipofuscinosis.

Yuza Y, Yokoi K, Sakurai K, Ariga M, Yanagisawa T, Ohashi T, Hoshi Y, Eto Y.

Pediatr Int. 2005 Dec;47(6):681-3. No abstract available.

PMID:
16354224
44.

An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor.

Kobayashi S, Ji H, Yuza Y, Meyerson M, Wong KK, Tenen DG, Halmos B.

Cancer Res. 2005 Aug 15;65(16):7096-101.

45.

Severe aplastic anaemia complicating Sjögren syndrome in a 2-year-old girl.

Akiyama M, Yanagisawa T, Yuza Y, Yokoi K, Fujisawa K, Kobayashi S, Eto Y.

Eur J Pediatr. 2005 Nov;164(11):700-2. Epub 2005 Jun 10. No abstract available.

PMID:
15947999
46.

The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22.

Taki T, Akiyama M, Saito S, Ono R, Taniwaki M, Kato Y, Yuza Y, Eto Y, Hayashi Y.

Oncogene. 2005 Aug 4;24(33):5191-7.

PMID:
15897884
47.

Successful treatment of Diamond-Blackfan anemia with metoclopramide.

Akiyama M, Yanagisawa T, Yuza Y, Yokoi K, Ariga M, Fujisawa K, Hoshi Y, Eto Y.

Am J Hematol. 2005 Apr;78(4):295-8.

48.

Gene and protein expression profiling during differentiation of neuroblastoma cells triggered by 13-cis retinoic acid.

Yuza Y, Agawa M, Matsuzaki M, Yamada H, Urashima M.

J Pediatr Hematol Oncol. 2003 Sep;25(9):715-20.

PMID:
12972807
49.

An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium.

Urashima M, Suzuki H, Yuza Y, Akiyama M, Ohno N, Eto Y.

Blood. 2000 Feb 15;95(4):1258-63. Erratum in: Blood 2000 Jun 15;95(12):3652.

50.

Max protein expression is associated with survival of children with lymphoblastic lymphoma.

Yuza Y, Kawakami M, Takagi K, Yamazaki Y, Urashima M.

Pediatr Int. 1999 Dec;41(6):637-40.

PMID:
10618883

Supplemental Content

Support Center